Literature DB >> 29433826

Cancer cervix: Establishing an evidence-based strategy, an experience of a tertiary care centre in India.

Shyam Kishore Shrivastava1, Shirley Lewis2, Supriya Chopra Sastri2, G Lavanya2, Umesh Mahantshetty2, Reena Engineer2.   

Abstract

Carcinoma cervix is a common cancer among Indian women. Evidence based management is essential for best practice in treatment of carcinoma cervix for its effective control. The current imaging system like CT, MRI and PET CT scans have contributed in identifying the patients for optimal treatment and delivering treatment accurately. For stages IB2 to IV, concurrent chemoradiation is advocated with improvement in overall survival proven with randomized trials. Brachytherapy is an integral part in the radiation treatment. Imaged-guided brachytherapy using MRI is desirable, however less expensive imaging modalities such as CT and ultrasonography has been evaluated. In special situation such as for HIV positive patients and patients with neuroendocrine tumors have role of radiotherapy. For further improvement in control of cancer, it is required to integrate basic research to answer clinically relevant questions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinoma cervix; Chemoradiation; Image-based brachytherapy; Radiotherapy

Mesh:

Year:  2018        PMID: 29433826     DOI: 10.1016/j.currproblcancer.2018.01.005

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  2 in total

Review 1.  Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.

Authors:  Anuj Kumar; Supriya Chopra; Sudeep Gupta
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

2.  Patterns of cervical cancer brachytherapy in India: results of an online survey supported by the Indian Brachytherapy Society.

Authors:  Abhishek Chatterjee; Surbhi Grover; Lavanya Gurram; Supriya Sastri; Umesh Mahantshetty
Journal:  J Contemp Brachytherapy       Date:  2019-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.